EUROPEAN NEUROPSYCHOPHARMACOLOGY

Scope & Guideline

Elevating Insights in Neuropsychopharmacological Science

Introduction

Immerse yourself in the scholarly insights of EUROPEAN NEUROPSYCHOPHARMACOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0924-977x
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1990 to 2024
AbbreviationEUR NEUROPSYCHOPHARM / Eur. Neuropsychopharmacol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'European Neuropsychopharmacology' focuses on the intricate relationships between neuroscience, pharmacology, and psychiatric disorders, aiming to advance knowledge in the field through rigorous research and innovative methodologies.
  1. Neuropsychopharmacology:
    The core focus of the journal is on neuropsychopharmacology, examining how drugs affect the brain and behavior, and exploring new pharmacological treatments for various psychiatric disorders.
  2. Biomarkers and Diagnostics:
    Research related to biomarkers for psychiatric conditions is prevalent, aiming to identify biological indicators that can aid in the diagnosis and treatment of mental health disorders.
  3. Clinical Trials and Treatment Efficacy:
    The journal places significant emphasis on clinical trials assessing the efficacy and safety of psychiatric medications, including novel treatments and repurposed drugs.
  4. Genetics and Epigenetics:
    There is a consistent focus on the genetic and epigenetic factors influencing psychiatric disorders, including the use of polygenic risk scores and genome-wide association studies.
  5. Translational Research:
    The journal encourages translational research that bridges the gap between laboratory findings and clinical applications, aiming to improve treatment strategies for mental health disorders.
  6. Neuroimaging and Brain Function:
    Neuroimaging studies are a key component, investigating brain structure and function in relation to psychiatric symptoms and treatment outcomes.
  7. Psychiatric Comorbidities:
    The exploration of comorbidities among psychiatric disorders, particularly how they interact with physical health and treatment responses, is a notable area of interest.
The journal has seen a rise in interest in several emerging themes, reflecting the evolving landscape of psychiatric research and treatment methodologies.
  1. Psychedelic Research:
    There is a growing body of research focusing on the therapeutic potential of psychedelics for various psychiatric conditions, including depression and anxiety, indicating a shift towards exploring alternative treatment modalities.
  2. Digital Psychiatry and Telehealth:
    The COVID-19 pandemic has accelerated interest in digital psychiatry, including telehealth solutions and mobile health applications, to enhance patient care and monitoring.
  3. Integrative Approaches to Mental Health:
    Emerging themes include integrative approaches that combine pharmacotherapy with psychotherapy, lifestyle interventions, and digital tools to enhance treatment outcomes.
  4. Neuroinflammation and Immune Response:
    Research exploring the links between neuroinflammation, immune responses, and psychiatric disorders is gaining momentum, highlighting the biological underpinnings of mental health conditions.
  5. Precision Psychiatry:
    An increasing focus on precision psychiatry, utilizing genetic, epigenetic, and environmental factors to tailor treatments to individual patients, is becoming prominent in published studies.
  6. Machine Learning and AI in Psychiatry:
    The application of machine learning and artificial intelligence in predicting treatment responses and understanding psychiatric disorders is an emerging trend, showcasing the integration of technology in mental health research.
  7. Gut-Brain Axis Research:
    Research into the gut-brain axis and its implications for mental health is rapidly expanding, with studies examining how gut microbiota influence psychiatric symptoms and treatment outcomes.

Declining or Waning

While the journal has evolved over time, certain themes have shown a decline in prominence, reflecting shifts in research interests and funding priorities.
  1. Traditional Pharmacotherapy:
    There appears to be a waning interest in traditional pharmacotherapy approaches, as newer and more innovative treatments, including psychedelic therapies and neuromodulation techniques, gain traction.
  2. Single-Disease Focus:
    Research focusing exclusively on single disease models is declining, with more studies adopting transdiagnostic approaches that consider overlapping symptoms and shared biological mechanisms.
  3. Basic Science without Clinical Application:
    There is a noticeable decrease in studies that focus solely on basic science without clear clinical applications, as the journal increasingly prioritizes research with direct implications for patient care.
  4. Longitudinal Studies without Genetic Components:
    Longitudinal studies that do not incorporate genetic or epigenetic analyses are becoming less common, as the integration of these factors is essential for understanding complex psychiatric disorders.

Similar Journals

Neurosciences

Innovating insights into mental health and neurological disorders.
Publisher: RIYADH ARMED FORCES HOSPITALISSN: 1319-6138Frequency: 4 issues/year

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

NeuroImage-Clinical

Innovative Insights into Neurological Disorders
Publisher: ELSEVIER SCI LTDISSN: 2213-1582Frequency:

NeuroImage-Clinical is a premier open access journal published by Elsevier Science Ltd, dedicated to advancing the field of clinical neuroimaging and its applications in a variety of neurological disorders. With an ISSN of 2213-1582, this journal has established itself as a leading source of innovative research since its inception in 2012, now continuing through 2024. Recognized for its high impact, it occupies the top quartile (Q1) in prestigious categories such as Cognitive Neuroscience, Neurology, and Radiology, affirming its relevance in clinical and research settings. Its Scopus rankings further exemplify its significant contribution to the disciplines of Radiology and Neurology, consistently placing it among the top tiers of journals in these fields. This journal not only provides critical insights for researchers and professionals but also serves as a valuable resource for students, fostering an understanding of the complexities in neuroimaging techniques and their implications for patient care. With open access options ensuring broad dissemination of knowledge, NeuroImage-Clinical plays a pivotal role in enhancing collaboration and innovation within the global neuroscience community.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Pioneering insights into psychiatric disorders and treatments.
Publisher: OXFORD UNIV PRESSISSN: 1461-1457Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, published by OXFORD UNIV PRESS, is a leading open-access journal in the fields of pharmacology and psychiatry, with an impressive impact factor reflecting its prominence in academic research. Since its inception in 1998, the journal has provided a crucial platform for the publication of high-quality research, offering insights into the effects of neuropharmacological agents on mental health. As of 2023, it ranks in the Q1 category for both Pharmacology and Psychiatry & Mental Health, underscoring its relevance and authority within the scientific community. With notable rankings in various medical subspecialties, it attracts contributions that advance our understanding of psychiatric disorders and therapeutic strategies. The accessible nature of the journal, following its transition to open access in 2015, has expanded its reach, making knowledge and findings readily available to researchers, professionals, and students globally. This commitment to disseminating impactful research ensures the journal remains at the forefront of neuropsychopharmacological advancements.

PSYCHIATRIC QUARTERLY

Elevating Clinical Insights in Psychiatry and Mental Health
Publisher: SPRINGERISSN: 0033-2720Frequency: 4 issues/year

PSYCHIATRIC QUARTERLY, published by Springer, stands as a pivotal resource in the field of psychiatry and mental health since its inception in 1927. With a reputable Q2 categorization in Psychiatry and Mental Health for 2023, this journal ranks impressively at #77 out of 567 in Scopus, placing it in the top 86th percentile of its category. Covering a diverse range of topics related to mental health, PSYCHIATRIC QUARTERLY aims to disseminate rigorous research findings, theoretical advancements, and clinical insights that contribute to improved mental health practices and policies. Although it does not offer open access, it provides substantial value to researchers, professionals, and students through its comprehensive analyses and scholarly articles. Located in New York, United States, the journal serves as an essential platform for advancing the understanding and treatment of psychiatric disorders, making it an invaluable addition to any academic library or research portfolio.

NERVENARZT

Bridging Clinical Practice and Theoretical Knowledge in Neurology
Publisher: SPRINGERISSN: 0028-2804Frequency: 12 issues/year

NERVENARZT, published by Springer, has established itself as a significant platform in the fields of Medicine, Neurology, and Psychiatry since its inception in 1947. With a focus on a wide array of topics in neurological and psychiatric health, the journal plays a crucial role in disseminating cutting-edge research and clinical insights that enhance understanding and treatment of neurological disorders. The journal is currently positioned in the Q3 category across various fields, reflecting its role in the academic community, and provides valuable contributions to both the clinical and theoretical aspects of neurology and psychiatry. While it does not offer open access options, NERVENARZT continues to make significant strides in literature with its comprehensive articles and research findings, aimed at researchers, healthcare professionals, and students interested in the latest developments in the neuroscience and mental health landscapes. Operating under rigorous academic standards, it holds respected rankings with Scopus, further underscoring its commitment to impactful scholarship through the years.

PSYCHIATRIC GENETICS

Transforming Mental Health Research through Genetic Discoveries
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0955-8829Frequency: 6 issues/year

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

Noropsikiyatri Arsivi-Archives of Neuropsychiatry

Exploring Innovative Paths in Mental Health Research
Publisher: TURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGIISSN: 1300-0667Frequency: 4 issues/year

Noropsikiyatri Arsivi-Archives of Neuropsychiatry is a prominent scholarly journal dedicated to advancing knowledge in the fields of neuropsychiatry and mental health. Published by the Turkish Neuropsychiatry Association, this journal aims to disseminate high-quality research that contributes to a deeper understanding of psychiatric disorders, innovative treatment modalities, and interdisciplinary approaches in neuroscience. Based in Turkey, the journal has been in circulation since its inception, with a rich history reflecting its commitment to addressing contemporary issues in mental health care. It is currently indexed under Scopus, with notable rankings in both Psychiatry and Mental Health (Rank #378/567, 33rd Percentile) and General Neuroscience (Rank #97/113, 14th Percentile), highlighting its increasing relevance and impact in the academia. Although it is not currently an open access journal, its contributions remain vital for researchers, professionals, and students who wish to stay abreast of the latest developments and research in neuropsychiatry.

PSYCHIATRY RESEARCH-NEUROIMAGING

Transforming Psychiatric Research Through Innovative Imaging
Publisher: ELSEVIER IRELAND LTDISSN: 0925-4927Frequency: 12 issues/year

PSYCHIATRY RESEARCH-NEUROIMAGING, published by Elsevier Ireland Ltd, stands at the intersection of neuroscience, psychiatry, and medical imaging, specializing in the latest advancements in neuroimaging techniques and their applications in psychiatric research. With a robust history since 1990, this esteemed journal features original research, reviews, and case studies that contribute significantly to the understanding of brain function in mental health disorders. Holding a notable Impact Factor and classified in Q2 for the fields of Neuroscience and Psychiatry and Q1 for Radiology, it serves as a vital resource for scholars and practitioners seeking to advance their knowledge in these domains. The journal is indexed in major databases, enhancing visibility and accessibility for global researchers. While it currently does not follow an open-access model, its reputable standing in Scopus ranks, alongside its targeted scope, makes it indispensable for those invested in neuroimaging research and its implications in psychiatry.

Brain Communications

Connecting Minds, Unlocking Potential
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Brain Communications is an esteemed, open-access academic journal published by Oxford University Press since 2019, focusing on the dynamic field of neuroscience. With a dedicated ISSN and an E-ISSN of 2632-1297, this journal aims to address the intricate relationships between brain functions, psychiatric disorders, and neurobiological mechanisms. The journal stands out in the academic realm, holding a prestigious Q1 ranking across several categories, including Biological Psychiatry, Cellular and Molecular Neuroscience, Neurology, and Psychiatry and Mental Health for 2023. Notably, it has also secured impressive Scopus ranks in various neuroscience and psychiatry fields, evidencing its commitment to high-quality research. With an impact factor reflective of its growing influence, Brain Communications provides accessible research findings to professionals, researchers, and students alike, fostering a deeper understanding of complex neurological phenomena. This innovative journal is pivotal for anyone involved in advancing knowledge in neuroscience and mental health.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Unveiling the Interdisciplinary Nexus of Mind and Brain
Publisher: SPRINGER HEIDELBERGISSN: 0940-1334Frequency: 6 issues/year

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.